Mechanisms involved in nicotinic acetylcholine receptor-induced neurotransmitter release from sympathetic nerve terminals in the mouse vas deferens

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Williams, Damian J ^a   Sidaway, Peter ^b   Cunnane, Thomas C ^a   Brain, Keith L ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CADMIUM; CALCIUM ION; EPIBATIDINE; METHYLLYCACONITINE; NEUROTRANSMITTER; NICOTINIC RECEPTOR; RYANODINE; TETRODOTOXIN; VOLTAGE GATED CALCIUM CHANNEL; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; FUSED HETEROCYCLIC RINGS; NICOTINIC AGENT; PYRIDINE DERIVATIVE;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ELECTROSTIMULATION; EXCITATORY JUNCTION POTENTIAL; EXTRACELLULAR CALCIUM; FACILITATION; INTRACELLULAR RECORDING; MALE; MICROELECTRODE; MOLECULAR MECHANICS; MOUSE; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE ENDING; NEUROTRANSMITTER RELEASE; NONHUMAN; SYMPATHETIC NERVE CELL; VAS DEFERENS; ADRENERGIC SYSTEM; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; EVOKED RESPONSE; INNERVATION; METABOLISM; PHYSIOLOGY; SYNAPTOSOME;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; EVOKED POTENTIALS; MALE; MICE; MICE, INBRED BALB C; NEUROTRANSMITTER AGENTS; NICOTINIC AGONISTS; PRESYNAPTIC TERMINALS; PYRIDINES; RECEPTORS, NICOTINIC; SYMPATHETIC NERVOUS SYSTEM; VAS DEFERENS;

EID: 84055207518     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029209     Document Type: Article

References (47)

1. Dani JA, Bertrand D, (2007) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47: 699-729.
2. Lindstrom J, (1997) Nicotinic acetylcholine receptors in health and disease. Mol Neurobiol 15: 193-222.
3. Picciotto MR, Zoli M, (2002) Nicotinic receptors in aging and dementia. J Neurobiol 53: 641-655.
4. Haass M, Kubler W, (1997) Nicotine and sympathetic neurotransmission. Cardiovasc Drugs Ther 10: 657-665.
5. Pidoplichko VI, DeBiasi M, Williams JT, Dani JA, (1997) Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390: 401-404.
6. Soliakov L, Gallagher T, Wonnacott S, (1995) Anatoxin-a-evoked [3H]dopamine release from rat striatal synaptosomes. Neuropharmacology 34: 1535-1541.
7. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA, (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383: 713-716.
8. Sharma G, Vijayaraghavan S, (2003) Modulation of presynaptic store calcium induces release of glutamate and postsynaptic firing. Neuron 38: 929-939.
9. Smith DA, Hoffman AF, David DJ, Adams CE, Gerhardt GA, (1998) Nicotine-evoked nitric oxide release in the rat hippocampal slice. Neurosci Lett 255: 127-130.
10. Dajas-Bailador F, Wonnacott S, (2004) Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 25: 317-324.
11. Sjöstrand NO, (1965) The adrenergic innervation of the vas deferens and accessory male genital organs. Acta Physiol Scand 257: 1-82.
12. Todorov L, Windisch K, Shersen H, Lajtha A, Papasova M, et al. (1991) Prejunctional nicotinic receptors involved in facilitation of stimulation-evoked noradrenaline release from the vas deferens of the guinea-pig. Br J Pharmacol 102: 186-190.
13. von Kügelgen I, Starke K, (1991) Release of noradrenaline and ATP by electrical stimulation and nicotine in guinea-pig vas deferens. Naunyn Schmiedebergs Arch Pharmacol 344: 419-429.
14. Brain KL, Trout SJ, Jackson VM, Dass N, Cunnane TC, (2001) Nicotine induces calcium spikes in single nerve terminal varicosities: a role for intracellular calcium stores. Neuroscience 106: 395-403.
15. Williams DJ, Brain KL, Cunnane TC, (2007) The effect of epibatidine on spontaneous and evoked neurotransmitter release in the mouse and guinea pig isolated vas deferens. Br J Pharmacol 150: 906-912.
16. Badio B, Daly JW, (1994) Epibatidine, a potent analgetic and nicotinic agonist. Mol Pharmacol 45: 563-569.
17. Brock JA, Cunnane TC, (1988) Electrical activity at the sympathetic neuroeffector junction in the guinea-pig vas deferens. J Physiol 399: 607-632.
18. Emptage NJ, Reid CA, Fine A, (2001) Calcium stores in hippocampal synaptic boutons mediate short-term plasticity, store-operated Ca2+ entry, and spontaneous transmitter release. Neuron 29: 197-208.
19. Alkondon M, Pereira EF, Wonnacott S, Albuquerque EX, (1992) Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol Pharmacol 41: 802-808.
20. Schulz DW, Zigmond RE, (1989) Neuronal bungarotoxin blocks the nicotinic stimulation of endogenous dopamine release from rat striatum. Neurosci Lett 98: 310-316.
21. Gerzanich V, Peng X, Wang F, Wells G, Anand R, et al. (1995) Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol 48: 774-782.
22. Zago WM, Markus RP, (1999) Melatonin modulation of presynaptic nicotinic acetylcholine receptors located on short noradrenergic neurons of the rat vas deferens: a pharmacological characterization. Braz J Med Biol Res 32: 999-1006.
23. Kristufek D, Stocker E, Boehm S, Huck S, (1999) Somatic and prejunctional nicotinic receptors in cultured rat sympathetic neurones show different agonist profiles. The Journal of physiology 516 (Pt 3): 739-756.
24. David R, Ciuraszkiewicz A, Simeone X, Orr-Urtreger A, Papke RL, et al. (2010) Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes. Eur J Neurosci 31: 978-993.
25. Fischer H, Orr-Urtreger A, Role LW, Huck S, (2005) Selective deletion of the alpha5 subunit differentially affects somatic-dendritic versus axonally targeted nicotinic ACh receptors in mouse. The Journal of physiology 563: 119-137.
26. Boehm S, Huck S, (1995) alpha 2-Adrenoreceptor-mediated inhibition of acetylcholine-induced noradrenaline release from rat sympathetic neurons: an action at voltage-gated Ca2+ channels. Neuroscience 69: 221-231.
27. Dolezal V, Lee K, Schobert A, Hertting G, (1996) The influx of Ca2+ and the release of noradrenaline evoked by the stimulation of presynaptic nicotinic receptors of chick sympathetic neurons in culture are not mediated via L-, N-, or P-type calcium channels. Brain Res 740: 75-80.
28. Sargent PB, (1993) The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 16: 403-443.
29. Egan TM, Khakh BS, (2004) Contribution of calcium ions to P2X channel responses. J Neurosci 24: 3413-3420.
30. Smith AB, Cunnane TC, (1996) Ryanodine-sensitive calcium stores involved in neurotransmitter release from sympathetic nerve terminals of the guinea-pig. J Physiol 497: 657-664.
31. Shoop RD, Chang KT, Ellisman MH, Berg DK, (2001) Synaptically driven calcium transients via nicotinic receptors on somatic spines. J Neurosci 21: 771-781.
32. Dajas-Bailador FA, Mogg AJ, Wonnacott S, (2002) Intracellular Ca2+ signals evoked by stimulation of nicotinic acetylcholine receptors in SH-SY5Y cells: contribution of voltage-operated Ca2+ channels and Ca2+ stores. J Neurochem 81: 606-614.
33. Le Magueresse C, Cherubini E, (2007) Presynaptic calcium stores contribute to nicotine-elicited potentiation of evoked synaptic transmission at CA3-CA1 connections in the neonatal rat hippocampus. Hippocampus 17: 316-325.
34. Welsby P, Rowan M, Anwyl R, (2006) Nicotinic receptor-mediated enhancement of long-term potentiation involves activation of metabotropic glutamate receptors and ryanodine-sensitive calcium stores in the dentate gyrus. Eur J Neurosci 24: 3109-3118.
35. Dickinson JA, Kew JN, Wonnacott S, (2008) Presynaptic α7- and β2-containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms. Mol Pharmacol 74: 348-359.
36. Llano I, Gonzalez J, Caputo C, Lai FA, Blayney LM, et al. (2000) Presynaptic calcium stores underlie large-amplitude miniature IPSCs and spontaneous calcium transients. Nat Neurosci 3: 1256-1265.
37. Collin T, Marty A, Llano I, (2005) Presynaptic calcium stores and synaptic transmission. Curr Opin Neurobiol 15: 275-281.
38. Brain KL, Bennett MR, (1997) Calcium in sympathetic varicosities of mouse vas deferens during facilitation, augmentation and autoinhibition. J Physiol 502: 521-536.
39. Cuprian AM, Solanki P, Jackson MV, Cunnane TC, (2005) Cholinergic innervation of the mouse isolated vas deferens. Br J Pharmacol 146: 927-934.
40. Parker LK, Shanks JA, Kennard JAG, Brain KL, (2010) Dynamic monitoring of NET activity in mature murine sympathetic terminals using a fluorescent substrate. British Journal of Pharmacology 159: 797-807.
41. Fuder H, Muscholl E, (1995) Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves. Rev Physiol Biochem Pharmacol 126: 265-412.
42. Wessler I, Kirkpatrick CJ, (2008) Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 154: 1558-1571.
43. Plenz E, (1990) Nicotinic facilitation of the electrically evoked release of noradrenaline from the guinea pig myenteric plexus. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 341: R86.
44. Nedergaard OA, Schrold J, (1977) The mechanism of action of nicotine on vascular adrenergic neuroeffector transmission. European Journal of Pharmacology 42: 315-329.
45. Richardt G, Haass M, Neeb S, Hock M, Lang RE, et al. (1988) Nicotine-induced release of noradrenaline and neuropeptide Y in guinea pig heart. Klinische Wochenschrift 66 (Suppl 11): 21-27.
46. Harte CB, Meston CM, (2008) Acute effects of nicotine on physiological and subjective sexual arousal in nonsmoking men: a randomized, double-blind, placebo-controlled trial. J Sex Med 5: 110-121.
47. Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, et al. (2008) Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med 148: 379-397.